- Home
- FCUV vs COCP Comparison
FCUV vs COCP Comparison
Compare FCUV & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- COCP
- Stock Information
- Founded
- FCUV 2012
- COCP 2006
- Country
- FCUV United States
- COCP United States
- Employees
- FCUV N/A
- COCP 11
- Industry
- FCUV Industrial Machinery/Components
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- FCUV Industrials
- COCP Health Care
- Exchange
- FCUV Nasdaq
- COCP Nasdaq
- Market Cap
- FCUV 16.7M
- COCP 15.5M
- IPO Year
- FCUV N/A
- COCP N/A
- Fundamental
- Price
- FCUV $1.94
- COCP $1.57
- Analyst Decision
- FCUV
- COCP Strong Buy
- Analyst Count
- FCUV 0
- COCP 1
- Target Price
- FCUV N/A
- COCP $6.00
- AVG Volume (30 Days)
- FCUV 21.9K
- COCP 170.9K
- Earning Date
- FCUV 08-12-2025
- COCP 08-14-2025
- Dividend Yield
- FCUV N/A
- COCP N/A
- EPS Growth
- FCUV N/A
- COCP N/A
- EPS
- FCUV N/A
- COCP N/A
- Revenue
- FCUV $432,983.00
- COCP N/A
- Revenue This Year
- FCUV N/A
- COCP N/A
- Revenue Next Year
- FCUV N/A
- COCP N/A
- P/E Ratio
- FCUV N/A
- COCP N/A
- Revenue Growth
- FCUV 140.82
- COCP N/A
- 52 Week Low
- FCUV $1.69
- COCP $1.12
- 52 Week High
- FCUV $10.90
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- FCUV 31.55
- COCP 45.42
- Support Level
- FCUV $1.87
- COCP $1.45
- Resistance Level
- FCUV $2.23
- COCP $1.71
- Average True Range (ATR)
- FCUV 0.18
- COCP 0.10
- MACD
- FCUV 0.01
- COCP -0.02
- Stochastic Oscillator
- FCUV 10.01
- COCP 25.87
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).